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Abstract Activity of phosphatidylinositol (PI) 3-kinase is
required for optimal migration of human neutrophils [Niggli
and Keller (1999) Eur. J. Pharmacol. 335, 43^52]. We have
tested the direct effect of a product of PI 3-kinase, phosphati-
dylinositol 3,4,5-trisphosphate (PIP3), on neutrophil migration.
To this end, a membrane-permeant ester of PIP3, dilauroyl
phosphatidylinositol 3,4,5-trisphosphate-heptakis-(acetooxy-
methyl)ester (PIP3/AM) was used. PIP3/AM (ED50 : 10^17
WM) induced development of polarity and accumulation of F-
actin in the leading lamellae in up to 70% of the cells. These cells
exhibited stimulated random migration, comparable to that
observed in uniform concentrations of chemotactic peptide.
Evidence is provided for a role of Rho-kinase and for activation
of PI 3-kinase in a positive feedback loop in PIP3/AM-induced
motility.
z 2000 Federation of European Biochemical Societies.
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1. Introduction
Directed migration is an indispensable feature of neutrophil
granulocytes in full¢lling their physiological role in host de-
fense against pathogens. However, the molecular mechanisms
of directed migration are as yet poorly understood. Upon
activation with chemotactic stimuli, neutrophils rapidly ex-
tend protrusions in all directions, concomitant with a marked
increase in total F-actin and cytoskeletal actin [1,2]. After a
few minutes of incubation with the stimulus, the cells assume
a polarized morphology with a broad front lamella and a
contracted tail [3,4]. The newly formed F-actin accumulates
in the front lamellae of polarized neutrophils [5]. How local-
ized actin polymerization, development of cell polarity and
locomotion are achieved and interconnected, is unclear,
although a complex network of chemoattractant-induced sig-
nalling pathways has been identi¢ed in neutrophils [6]. We
have recently provided evidence for a role of the enzyme phos-
phatidylinositol (PI) 3-kinase in chemotactic peptide-induced
development of polarity and migration [7]. Similarly, Knall et
al. [8] have shown that PI 3-kinase activity is also required for
Il-8-induced neutrophil migration.
Activation of PI 3-kinase in human neutrophils via occu-
pancy of receptors of formylated peptides results in increased
formation of phosphatidylinositol 3,4,5-trisphosphate (PIP3)
and phosphatidylinositol 3,4-diphosphate (PI(3,4)P2) [9,10].
The downstream targets of these lipids involved in neutrophil
migration have not yet been identi¢ed. As shown recently, PI
3-kinase not only produces PIP3 and PI(3,4)P2 but could also
act by phosphorylating proteins [11].
We now wanted to know whether one of the products of PI
3-kinase, PIP3, is su⁄cient to induce neutrophil motility. We
have therefore investigated the e¡ect of directly introducing
PIP3 into the neutrophils. This was achieved by using a re-
cently synthesized membrane-permeant ester of PIP3 : dilauroyl
phosphatidylinositol 3,4,5-trisphosphate-heptakis-(acetooxy-
methyl)ester (PIP3/AM) [12]. This compound crosses the
plasma membrane by passive di¡usion and is hydrolyzed by
intracellular esterases, generating PIP3 inside the cells. I show
here that introduction of a membrane-permeable ester of PIP3
into the cells is su⁄cient to induce development of polarity,
polarized accumulation of F-actin and migration in human
neutrophils.
2. Materials and methods
2.1. Reagents and suppliers
Reagents and suppliers were: N-formyl-L-norleucyl-L-leucyl-L-phe-
nylalanyl-L-norleucyl-L-tyrosyl-L-lysine (fNLPNTL), Bachem, Buben-
dorf, Switzerland; human serum albumin (HSA), Behringwerke, Mar-
burg, Germany; LY294002, Alexis Corporation, La«ufel¢ngen,
Switzerland; wortmannin, Sigma, St Louis, MO, USA.
PIP3/AM was a kind gift from Dr. R.Y. Tsien (Howard Hughes
Medical Institute, University of California, San Diego, CA, USA).
PIP3/AM was prepared as a stock solution of 25 mM in DMSO
and stored at 320‡C. Addition of PIP3/AM to the cells resulted in
a ¢nal concentration of maximally 0.4% DMSO. DMSO alone, up to
0.4%, had no e¡ects in control experiments. Y-27632 was kindly pro-
vided by Yoshitomi Pharmaceutical Industries, Ltd., Japan. Stock
solutions of Y-27632 (10 mM) were prepared in H2O and aliquots
were stored at 320‡C.
2.2. Isolation of human neutrophils
Neutrophils were isolated from heparinized human blood (10 units/
ml) as detailed previously [13]. Neutrophils were resuspended in Gey’s
medium containing 138 mM NaCl, 6 mM KCl, 1 mM Na2HPO4,
5 mM NaHCO3, 5.5 mM glucose, 20 mM HEPES, pH 7.3, without or
with divalent cations and HSA, depending on the assays (see Section
3). Especially for the experiments with wortmannin, in order to min-
imize variability of ¢ndings possibly due to donor variability, neutro-
phils prepared from the blood of at least three donors were combined.
2.3. Analysis of e¡ects of PIP3/AM and of PIP3 on neutrophil shape
Neutrophils (3U106 cells/ml) were incubated in medium in a recip-
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rocating waterbath at 37‡C without or with inhibitors and DMSO or
PIP3/AM as indicated in Section 3. The reaction was stopped by ¢xing
the cells in 1% glutaraldehyde (¢nal concentration) for 30 min. Cell
shape was determined as described [14].
As a control, neutrophils (3U106 cells/ml) were also incubated for
45 min at 37‡C in medium lacking divalent cations and HSA with 5 or
10 WM PIP3, obtained from Matreya Inc. (Pleasant Gap, PA, USA),
followed by analysis of morphology. A PIP3 stock solution (0.4 mM)
was prepared by dissolving the lipid in a bu¡er containing 20 mM
HEPES, pH 7.4. This stock solution was sonicated for 2 min in a bath
sonicator.
2.4. Locomotion
For locomotion assays, a discontinuous Ficoll-metrizoate gradient
instead of NIM was used for removal of mononuclear cells [7]. Neu-
trophils (6U106/ml) were incubated in Gey’s medium without divalent
cations, containing 1% HSA, with 0.4% DMSO or 25 WM PIP3/AM
for 45 min at 37‡C. The cells were centrifuged at 300Ug for 5 min and
resuspended in Gey’s medium containing 2.5% HSA, 1.1 mM CaCl2,
1 mM MgCl2 and 0.1 mM EGTA. Subsequently, the percentage of
migrating cells and the mean speed of migrating cells was determined
as described previously [7].
2.5. Localization of F-actin
The intracellular localization of F-actin was determined by NBD-
phallacidin-staining of paraformaldehyde-¢xed cells as described [15],
with modi¢cations [16]. Neutrophils were incubated without or with
PIP3/AM as described in Section 3. The cells were then ¢xed in 4%
paraformaldehyde and stained with NBD-phallacidin [16].
2.6. Analysis of phosphorylation of p42/44 mitogen-activated protein
kinase (MAPK) (extracellular signal-regulated kinase, ERK) in
neutrophils
Neutrophils (107/ml) were exposed to diisopropyl£uorophosphate
as described [7] and resuspended in Gey’s medium lacking divalent
cations and HSA. Aliquots (0.45 ml) were exposed to stimuli and
inhibitors as described in Section 3. The reaction was stopped by
centrifugation. The pelleted cells (2.5U106 cells per lane) were solu-
bilized in a bu¡er containing 1% SDS, 50 mM DTT, 15% (v/v) glyc-
erol, 62.5 mM Tris, pH 6.8, 0.001% bromophenol blue, followed by
separation of proteins on a 5^10% SDS^polyacrylamide gradient gel
and immunoblotting using a polyclonal antibody speci¢c for p42/44
MAPK phosphorylated on threonine and tyrosine, diluted 1:1000
(New England Biolabs, Beverly, MA, USA).
2.7. Statistical analysis of data
Di¡erences between data were analyzed with the Student’s t-test for
paired data, with a P value of 6 0.05 considered signi¢cant. Data
correspond to the mean þ S.E.M. of n independent experiments.
3. Results
3.1. PIP3/AM induces development of polarity and migration in
human neutrophils
We studied the e¡ect of incubating human neutrophils for
45 min at 37‡C with PIP3/AM on the shape of these cells. As
shown in Fig. 1, this treatment caused a dose-dependent
marked increase in the percentage of polarized cells. The ma-
jority (80^98%) of untreated cells were spherical with a
smooth surface, 0^11% showing spontaneous polarization
(Fig. 2A). This morphology was markedly changed by incu-
bation with PIP3/AM, resulting in 30^70% of polarized cells
with contracted tail and anterior lamellae (Fig. 2C), compa-
rable to the morphology of cells incubated with chemotactic
peptide (Fig. 2B; [7]). This response was maximal at 25^50
WM of PIP3/AM, and half-maximal e¡ects were obtained at
10^17 WM (Fig. 1). For comparison, incubation of neutrophils
with 1 nM fNLPNTL for 30 min results in induction of polar-
ity in 80^90% of the cells [7]. The e¡ects of PIP3/AM were
obtained in bu¡ers without CaCl2 and MgCl2. In Gey’s me-
dium containing 1.1 mM CaCl2, 1 mM MgCl2, and 0.1 mM
EGTA, 25 WM PIP3/AM induced polarity in only 11^16% of
the cells. Divalent cations are known to promote fusion of
PIP2 micelles into insoluble aggregates [17], and probably
similarly a¡ect PIP3/AM, preventing optimal activation of
cells.
Incubation of neutrophils for 45 min at 37‡C with a com-
mercially available non-membrane-permeant PIP3 analogue
(15 WM) did not induce a signi¢cant increase in the percentage
of polarized cells (14 þ 6% polarized cells in controls versus
15 þ 6% polarized cells after incubation with the PIP3 ana-
logue, n = 3). Higher concentrations of the lipid induced cell
aggregation. These data suggest that PIP3/AM acts intracel-
lularly.
Development of polarity is thought to be a prerequisite for
cell migration [3]. We analyzed whether cells polarized upon
incubation with PIP3/AM were also able to migrate. Migra-
tion was assessed by preincubating cells with 25 WM PIP3/AM
in medium lacking divalent cations, in order to avoid adverse
e¡ects on PIP3/AM, followed by centrifugation and resuspen-
sion in medium with divalent cations. Migration of cells was
then assessed by videomicroscopy in the absence of PIP3/AM
in the medium. As shown in Table 1, this pretreatment of cells
with 25 WM PIP3/AM resulted in signi¢cantly increased mi-
gration in 47^61% of the cells with a mean speed approaching
that of cells stimulated with chemotactic peptide (Table 1). No
obvious di¡erence could be detected in shape changes ob-
served during migration of cells induced by treatment with
PIP3/AM and chemotactic peptide (data not shown). The di-
rection of migration was random, comparable to migration in
uniform concentrations of chemotactic peptide.
3.2. PIP3/AM induces polarized accumulation of F-actin in
neutrophils
As shown in Fig. 2C,CP, neutrophils polarized by incuba-
tion with 25 WM PIP3/AM for 45 min show not only a clearly
polarized shape, but also markedly accumulate F-actin in the
leading lamellae, comparable to the e¡ect induced by incuba-
Fig. 1. Concentration-dependent e¡ect of PIP3/AM on the shape of
human neutrophils. Neutrophils (3U106 cells/ml) were incubated for
45 min at 37‡C in Gey’s medium lacking divalent cations and HSA
in the absence or presence of increasing concentrations of PIP3/AM,
as indicated. Cells were subsequently ¢xed with glutaraldehyde, and
the percentage of polarized cells was determined (100 cells per sam-
ple inspected). Mean þ S.E.M. of three independent experiments (50
WM PIP3/AM: n = 2).
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tion with fNLPNTL (Fig. 2B,BP). In contrast, resting cells
show a di¡use cytoplasmic distribution of F-actin (Fig.
2A,AP). In 81 out of 100 cells polarized by addition of 25
WM PIP3/AM we observed this polar accumulation of F-actin
as compared to 83 out of 100 cells polarized in the presence of
1 nM fNLPNTL. PIP3/AM thus induces F-actin reorganiza-
tion comparable to chemotactic peptide.
3.3. Identi¢cation of signalling pathways located downstream of
PIP3
We have previously shown that activity of the Rho-associ-
ated coiled coil kinase appears to be required for chemotactic
peptide-induced development of polarity and migration in
neutrophils [18]. We therefore studied a possible role of acti-
vation of Rho-kinase in PIP3/AM-induced neutrophil shape
changes. Preincubation with 10 WM of Y-27632, a selective
inhibitor of Rho-kinase [19], signi¢cantly inhibited develop-
ment of polarity induced by PIP3/AM by 82 þ 5% (n = 3), as
shown in Fig. 3. Cells became spherical with unifocal surface
projections, comparable to cells preincubated with Y-27632
prior to addition of chemotactic peptide (Fig. 3A, panel c).
PIP3 may thus act by stimulating Rho which activates Rho-
kinase. However, Y-27632 could not suppress membrane pro-
trusion, suggesting that a target of PIP3/AM other than Rho-
kinase is essential for this process.
We have shown previously that wortmannin, a potent PI 3-
kinase inhibitor [20], markedly reduces fNLPNTL-induced
development of polarity and migration in neutrophils, sug-
gesting that products of PI 3-kinase, possibly PIP3, are im-
portant signalling substances for migration [7]. Shape changes
induced by PIP3/AM should thus not anymore be susceptible
to wortmannin. Unexpectedly, 50 nM wortmannin inhibited
these shape changes almost completely, by 95 þ 6% (Fig. 3). It
cannot be excluded that even low, nanomolar concentrations
of wortmannin act also on other enzymes [21]. We therefore
tested the e¡ect of a structurally di¡erent PI 3-kinase inhib-
Fig. 2. Morphology and F-actin localization of neutrophils exposed
to 25 WM PIP3/AM. Cells (3U106 cells/ml) were incubated for 45
min at 37‡C in Gey’s medium lacking divalent cations and HSA in
the absence (A, AP) or presence of 25 WM PIP3/AM (C, CP). For
comparison, cells are shown which were preincubated for 10 min at
37‡C in medium followed by the addition of 1 nM fNLPNTL and
a further incubation for 30 min (B, BP). Cells were subsequently
¢xed and stained with rhodamine phalloidin to visualize F-actin.
Photographs were obtained with Nomarski optics (A^C) and in
£uorescent light (AP^CP). For cells incubated with PIP3/AM, several
typical examples of cells are shown. Bar: 10 Wm.
Table 1
PIP3/AM stimulates neutrophil migration
Additions Migrating
cells (%)
Speed of migrating cells
(Wm/min)
Medium 5 þ 3 0.7 þ 0.4
fNLPNTL (1 nM) 48 9.8
PIP3/AM (25 WM) 57 þ 3 6.2 þ 1.2
Neutrophils (6U106/ml) were either incubated with 0.4% DMSO or
with PIP3/AM (25 WM) for 45 min, or, after a preincubation with
0.4% DMSO for 15 min, with 1 nM fNLPNTL for 30 min at 37‡C
in Gey’s medium containing 1% HSA, without divalent cations, fol-
lowed by centrifugation and resuspension in Gey’s medium contain-
ing 2.5% HSA and divalent cations. In case of fNLPNTL, 1 nM
fNLPNTL was added after centrifugation. Subsequently the percent-
age of migrating cells and the mean speed of migrating cells was
determined in slide coverslip preparations at 37‡C using video-
microscopy. Mean þ S.E.M. of four independent experiments
(+fNLPNTL: n = 2).
Fig. 3. E¡ects of inhibitors of Rho-kinase and PI 3-kinase on PIP3/
AM-induced shape changes in neutrophils. A: Neutrophils (3U106
cells/ml) were preincubated in Gey’s medium lacking divalent cati-
ons and HSA in the absence (a, b) or in the presence of 10 WM Y-
27632 (c) or 50 nM wortmannin (d) for 10 min at 37‡C, followed
by the addition of DMSO, 0.4% (a) or 25 WM PIP3/AM (b, c, d)
and a further incubation for 40 min. Subsequently cells were ¢xed
with glutaraldehyde and photographed using Normarski optics. Bar,
10 Wm. In panel b, arrows indicate the leading lamella and arrow-
heads the contracted tail. B: Quantitative evaluation of the experi-
ment shown in A. Neutrophils (3U106 cells/ml) were preincubated
in Gey’s medium lacking divalent cations and HSA in the absence
or in the presence of 50 nM wortmannin (WM) or 10 WM Y-27632
(Y) for 10 min at 37‡C as indicated, followed by a further incuba-
tion in the absence or presence of 25 WM PIP3/AM for 40 min.
Subsequently cells were ¢xed with glutaraldehyde and the percentage
of polarized cells was determined. Mean þ S.E.M. of 3^4 independ-
ent experiments.
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itor, LY294002 [22]. Preincubation of cells with 75 WM of
LY294002 suppressed PIP3/AM-induced polarity by
42 þ 11% (n = 6). LY294002 was thus clearly less e¡ective
than wortmannin, suggesting that PI 3-kinase, activated
downstream of PIP3, contributes to migration, but that part
of the e¡ect of wortmannin may be explained by inhibition of
other enzymes.
The unexpected inhibitory e¡ect of wortmannin and
LY294002 suggests that incubation of cells with PIP3/AM
results in activation of PI 3-kinase by a positive feedback
loop. We therefore tested whether PIP3/AM induces activa-
tion of a target of PI 3-kinase, p42/44 MAPK (ERK), by
analyzing phosphorylation of MAPK (indicative of activa-
tion) using a phosphorylation-speci¢c antibody. It has been
shown previously that chemotactic peptides induce an increase
in phosphorylation and activation of p42/44 MAPK in human
neutrophils and that this process can be suppressed by prein-
cubation of cells with wortmannin [23]. As shown in Fig. 4A
(lanes 5, 6), in cells exposed to 1 nM fNLPNTL for 5 min
phosphorylation of p42/44 MAPK indeed was increased 16-
fold. Similarly, incubation of neutrophils with 25 WM PIP3/
AM induced a very marked increase in phosphorylation of
p42/44 MAPK 25 min after addition of the compound (Fig.
4B), and a smaller increase 30 min after its addition (Fig. 4A,
lane 2). At 45 min after addition of the compound, phosphor-
ylation of p44 MAPK was decreased almost to control values
whereas that of p42 MAPK was still increased about 2-fold
(Fig. 4A, lane 4). We then wanted to know whether PIP3/AM-
induced MAPK activation is due to activation of PI 3-kinase
by testing the e¡ect of wortmannin. As shown in Fig. 4B,
preincubation of cells with 50 nM wortmannin prior to addi-
tion of PIP3/AM did completely prevent increased phosphor-
ylation of p44 MAPK, whereas that of p42 MAPK was also
markedly suppressed (44^72% inhibition). This ¢nding sug-
gests indeed that PIP3/AM induces activation of PI 3-kinase
in a positive feedback loop, which then results in increased
phosphorylation and activation of p42/44 MAPK.
4. Discussion
Our results show that an intracellular increase of PIP3 in
human neutrophils, resulting from incubation of the cells with
a membrane-permeant ester of this lipid, induces development
of polarity, accumulation of F-actin in the anterior lamellae
and migration. These responses are indistinguishable from
those observed in uniform concentrations of chemotactic pep-
tide. Signi¢cant e¡ects were obtained at 10^25 WM of the
membrane-permeant ester. For comparison, in human neutro-
phils PIP3 levels in resting cells amount to 50 pmol per ml of
packed cells [24]. This level rises to a peak value of 2 nmol per
ml packed cells, corresponding to a concentration of 2 WM
[24]. We need approximately 10 times more for a maximal
response. This may be due to incomplete entry and hydrolysis
of PIP3/AM into the cell. Moreover, very likely only PIP3
incorporated into plasma membranes may be active, but
part of the hydrolyzed ester may incorporate also into other
cellular membranes. PIP3 will also be rapidly metabolized.
Direct addition of PIP3 micelles to NIH 3T3 ¢broblasts has
been shown previously to induce ¢broblast motility, presum-
ably by fusion of the micelles with the plasma membrane [25].
In these experiments, the e¡ect of PIP3 on motility was only
about 25% of the response induced by PDGF. In contrast we
observed no signi¢cant response when micelles of a non-mem-
brane-permeant PIP3 analogue were added to the neutrophils,
suggesting that these cells do not spontaneously incorporate
su⁄cient amounts of this lipid into the inner lea£et of their
plasma membrane. PIP3/AM however induced e¡ects compa-
rable to that of the potent chemoattractant fNLPNTL. Very
likely, uptake of membrane-permeant PIP3/AM is much more
e⁄cient than that of PIP3. Our results also show that an
increase in PIP3 alone can induce a migratory response not
only in slow moving ¢broblasts but also in neutrophils, which
belong to the fastest moving mammalian cells known.
Comparable to the e¡ect of Rho-kinase inhibition on che-
motactic peptide-stimulated cells [18], the Rho-kinase inhibi-
tor Y-27632 suppressed tail contraction, but not formation of
surface protrusions in PIP3/AM-activated cells (Fig. 3A, panel
c). Our data suggest that PIP3/AM activates the Rho/Rho-
kinase pathway in human neutrophils. Several recent reports,
based mainly on in vitro observations, similarly suggest that
phosphoinositides can activate Rho-family proteins. The
mechanism of this activation could involve both activation
of guanosine nucleotide exchange factors, which then stimu-
late small G-proteins, and direct e¡ects of these lipids on
small G-proteins by inducing their membrane association or
acting themselves as guanosine nucleotide exchange factors.
For example, PIP3 and phosphatidylinositol 4,5-bisphosphate,
but not phosphatidylinositol, appear to induce F-actin assem-
bly in Xenopus egg extracts, by a mechanism involving acti-
vation of the small GTP-binding protein Cdc42 [26]. In an-
other report, phosphatidylinositol 4,5-bisphosphate has been
shown to stimulate GDP release from Cdc42 and RhoA [27].
Our data now suggest that phosphoinositide-induced activa-
tion of Rho-family proteins also occurs in intact cells.
The fact that the PIP3/AM-induced polarity was inhibited
by low, nanomolar concentrations of wortmannin was unex-
pected and may be partly explained by inhibition of enzymes
Fig. 4. MAPK phosphorylation in neutrophils exposed to PIP3/AM
or fNLPNTL. A: Neutrophils were preincubated in the absence
(lanes 1, 3) or in the presence of PIP3/AM (25 WM) (lanes 2, 4) for
30 (lanes 1, 2) or 45 (lanes 3, 4) min at 37‡C. For comparison, neu-
trophils were either incubated for 15 min in medium (lane 5) or ex-
posed for 5 min to 1 nM fNLPNTL after 10 min of preincubation
at 37‡C (lane 6). B: Neutrophils were preincubated for 10 min at
37‡C in the absence or presence of 50 nM wortmannin, followed by
addition of medium or PIP3/AM (25 WM) and a further incubation
for 25 min, as indicated. Subsequently, for A and B, cells were solu-
bilized and subjected to gel electrophoresis and immunoblotting us-
ing an antibody speci¢c for phosphorylated p42/44 MAPK (ERK).
Arrows indicate the bands of MAPK of 42 000 and 44 000 Da. The
data shown are representatives of two independent experiments with
comparable results.
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other than PI 3-kinase by wortmannin. However, LY294002,
a structurally di¡erent inhibitor of PI 3-kinase, also signi¢-
cantly attenuated PIP3/AM-induced development of polarity,
suggesting that PIP3 leads to activation of PI 3-kinase. This
would imply the interesting possibility of a positive feedback
loop. Indeed, we provide evidence for the fact that incubation
of cells with PIP3/AM induces wortmannin-sensitive activa-
tion of a target of PI 3-kinase, p42/44 MAPK (Fig. 4). Acti-
vation of this enzyme has been shown to result from phos-
phorylation of MAPK-kinase by PI 3-kinase [11]. Products
other than PIP3, that is, PI(3,4)P2 or the protein kinase activ-
ity of PI 3-kinase, may thus play an important role in PIP3/
AM-induced neutrophil migration. The same processes seem
to be operative in the chemotactic peptide-induced responses,
as PIP3/AM was only partially able to overcome inhibition of
chemotactic peptide-induced polarity by wortmannin (Niggli,
unpublished observations).
In summary, we have provided novel evidence that a mem-
brane-permeant ester of PIP3 can initiate motility in human
neutrophils. Activation of Rho-kinase and activation of PI 3-
kinase in a positive feedback loop appear to be required for
this event.
Acknowledgements: We thank Kathy Mujynya-Ludunge for excellent
technical assistance, Dr. E. Sigel for critical reading of the manuscript
and Professor H.U. Keller for continuous support. We are grateful to
Dr. R.Y. Tsien for generous gifts of PIP3/AM and to Ms. Akiko
Yoshimura (Yoshitomi Pharmaceutical Research Industries, Ltd., Ja-
pan) for the generous supply of Y-27632. This work was supported by
the Swiss National Foundation for Scienti¢c Research.
References
[1] Rao, K.M.K. and Varani, J. (1982) J. Immunol. 129, 1605^1607.
[2] White, J.R., Naccache, P.H. and Sha’a¢, R.I. (1983) J. Biol.
Chem. 258, 14041^14047.
[3] Devreotes, P.N. and Zigmond, S.H. (1988) Annu. Rev. Cell Biol.
4, 649^686.
[4] Parent, C.A. and Devreotes, P.N. (1999) Science 284, 765^770.
[5] Zigmond, S.H. (1993) Cell Motil. Cytoskelet. 25, 309^316.
[6] Bokoch, G.M. (1995) Blood 86, 1649^1660.
[7] Niggli, V. and Keller, H.U. (1997) Eur. J. Pharmacol. 335, 43^52.
[8] Knall, C., Worthen, G.S. and Johnson, G.L. (1997) Proc. Natl.
Acad. Sci. USA 94, 3052^3057.
[9] Traynor-Kaplan, A.E., Thompson, B.L., Harris, A.L., Taylor,
P., Omann, G.M. and Sklar, L.A. (1989) J. Biol. Chem. 264,
15668^15673.
[10] Eberle, M., Traynor-Kaplan, A.E., Sklar, L.A. and Norgauer, J.
(1990) J. Biol. Chem. 265, 16725^16728.
[11] Bondeva, T., Pirola, L., Bulgarelli-Leva, G., Rubio, I., Wetzker,
R. and Wymann, M.P.C. (1998) Science 282, 293^296.
[12] Jiang, T., Sweeney, G., Rudolf, M.T., Klip, A., Traynor-Kaplan,
A. and Tsien, R.Y. (1998) J. Biol. Chem. 273, 11017^11024.
[13] Niggli, V. and Keller, H.U. (1999) Exp. Cell Res. 250, 558^568.
[14] Keller, H.U. and Niggli, V. (1994) J. Cell Physiol. 161, 526^536.
[15] Howard, T.H. and Meyer, W.H. (1984) J. Cell Biol. 98, 1265^
1271.
[16] Keller, H.U. and Niggli, V. (1995) Eur. J. Cell Biol. 66, 157^164.
[17] Janmey, P.A., Iida, K., Yin, H.L. and Stossel, T.P. (1987) J. Biol.
Chem. 262, 12228^12235.
[18] Niggli, V. (1999) FEBS Lett. 445, 69^72.
[19] Uehata, M., Ishizaki, T., Satoh, H., Ono, T., Kawahara, T.,
Morishita, T., Tamakawa, H., Yamagami, K., Inui, J., Maeka-
wa, M. and Narumiya, S. (1997) Nature 389, 990^994.
[20] Arcaro, A. and Wymann, M.P.C. (1993) Biochem. J. 296, 297^
301.
[21] Cross, M.J., Stewart, A., Hodkin, M.N., Kerr, D.J. and Wake-
lam, M.J.O. (1995) J. Biol. Chem. 270, 25352^25355.
[22] Vlahos, C.J., Matter, W.F., Brown, R.F., Traynor-Kaplan, A.E.,
Heyworth, P.G., Prossnitz, E.R., Ye, R.D., Marder, P., Schelm,
J.A., Rothfuss, K.J., Serlin, B.S. and Simpson, P.J. (1995)
J. Immunol. 154, 2413^2422.
[23] Downey, G.P., Butler, J.R., Brumell, J., Borregaard, N., Kjeld-
sen, L., Sue-A-Quan, A.K. and Grinstein, S. (1996) J. Biol.
Chem. 271, 21005^21011.
[24] Stephens, L.R., Hughes, K.T. and Irvine, R.F. (1991) Nature
351, 33^39.
[25] Derman, M.P., Toker, A., Hartwig, J.H., Spokes, K., Falck,
J.R., Chen, C.-S., Cantley, L.C. and Cantley, L.G. (1997)
J. Biol. Chem. 272, 6465^6470.
[26] Ma, L., Cantley, L.C., Janmey, P.A. and Kirschner, M.W. (1998)
J. Cell Biol. 140, 1125^1136.
[27] Zheng, Y., Glaven, J.A., Wu, W.J. and Cerione, R.A. (1996)
J. Biol. Chem. 271, 23815^23819.
FEBS 23667 8-5-00
V. Niggli/FEBS Letters 473 (2000) 217^221 221
